Skip to main content

Sandra Mancilla Zamora

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sandra Mancilla Zamora

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Degrees:
Stable animal experimentation course. ABC function in 2020
Senior Clinical Analysis Technician in 2005
Higher Techniques in Pathological Anatomy and Cytology in 2001.

Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017
Technician in charge of the histology section of FVPR and the DDT group of the VHIR.
With knowledge in environment and quality management at ISO 9001. Application management, internal positions…
They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune.
I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing.
Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.

Projects

Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease

IP: -
Collaborators: Ibane Abasolo Olaortua, Simon Schwartz Navarro, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua, Ibane Abasolo Olaortua
Funding agency: EUROPEAN COMMISSION
Funding: 266300.8
Reference: SMART4FABRY_H2020NMBP2016
Duration: 01/01/2017 - 31/12/2020

NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy

IP: Simon Schwartz Navarro
Collaborators: Ibane Abasolo Olaortua, Joaquin Seras Franzoso, Tamara Del Rio Higueras, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez
Funding agency: EUROPEAN COMMISSION
Funding: 630633.55
Reference: NOCANTHER_H2020NMP2015
Duration: 01/04/2016 - 30/09/2021

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model.

Related professionals

Sonia  Monreal  Clua

Sonia Monreal Clua

Predoctoral researcher
Biomedical Research in Gynaecology
Read more
Rosanna Paciucci Barzanti

Rosanna Paciucci Barzanti

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Pablo Vilalta Gras

Pablo Vilalta Gras

Zelador/a
General Services and Infrastructure
Manager
Read more
Carmen Sanchez Suarez

Carmen Sanchez Suarez

Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.